Literature DB >> 18680105

Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation.

Yaowu He1, Joseph A Rothnagel, Michael R Epis, Peter J Leedman, Ross Smith.   

Abstract

Over-expression of heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 is regarded as an early marker for several cancers. This protein is associated with proto-oncogenes and tumor suppressor genes and has itself been described as a proto-oncogene. Our earlier experiments drew a connection between hnRNP A2/B1 levels and cell proliferation and raised the possibility that this protein contributes to the uncontrolled cell division that characterizes cancer. Limited knowledge of the downstream targets of hnRNP A2/B1 has, however, precluded a clear understanding of their roles in cancer cell growth. To define the pathways in which this protein acts we have now carried out microarray experiments with total RNA from Colo16 epithelial cells transfected with an shRNA that markedly suppresses hnRNP A2/B1 expression. The microarray data identified 123 genes, among 22 283 human gene probe sets, with altered expression levels in hnRNP A2/B1-depleted cells. Ontological analysis showed that many of these downstream targets are involved in regulation of the cell cycle and cell proliferation and that this group of proteins is significantly over-represented amongst the affected proteins. The changes detected in the microarray experiments were confirmed by real-time PCR for a subset of proliferation-related genes. Immunoprecipitation-RT-PCR demonstrated that hnRNP A2/B1 formed complexes with the transcripts of many of the verified downstream genes, suggesting that hnRNP A2/B1 contributes to the regulation of these genes. These results reinforce the conclusion that hnRNP A2/B1 is associated with cellular processes that affect the cell cycle and proliferation. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18680105     DOI: 10.1002/mc.20467

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  10 in total

Review 1.  Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA.

Authors:  Mo Chen; Jian Zhang; James L Manley
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

2.  Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.

Authors:  Kamyar Hadian; Michelle Vincendeau; Nina Mäusbacher; Daniel Nagel; Stefanie M Hauck; Marius Ueffing; Abraham Loyter; Thomas Werner; Horst Wolff; Ruth Brack-Werner
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

3.  Histochemical mapping of hnRNP A2/B1 in rat brain after ischemia-reperfusion insults.

Authors:  Yichen Liu; Yan Gao; Yan Wu; Yonghong Wu; Hangyan Wang; Chenggang Zhang
Journal:  J Histochem Cytochem       Date:  2010-04-26       Impact factor: 2.479

4.  Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer.

Authors:  Xiao-Han Qu; Jin-Lu Liu; Xin-Wen Zhong; X I Li; Qi-Gang Zhang
Journal:  Oncol Lett       Date:  2015-07-03       Impact factor: 2.967

5.  Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.

Authors:  Huaqing Cui; Feng Wu; Yanling Sun; Guocai Fan; Qingming Wang
Journal:  BMC Cancer       Date:  2010-07-06       Impact factor: 4.430

6.  hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.

Authors:  Yang Xuan; Jingshu Wang; Liying Ban; Jian-Jun Lu; Canhui Yi; Zhenglin Li; Wendan Yu; Mei Li; Tingting Xu; Wenjing Yang; Zhipeng Tang; Ranran Tang; Xiangsheng Xiao; Songshu Meng; Yiming Chen; Quentin Liu; Wenlin Huang; Wei Guo; Xiaonan Cui; Wuguo Deng
Journal:  Mol Oncol       Date:  2015-11-30       Impact factor: 6.603

7.  Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.

Authors:  Dongliang Li; Zejun Fu; Chaoqun Dong; Yongming Song
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging.

Authors:  Abhinav Bhise; Hyun Park; Woonghee Lee; Swarbhanu Sarkar; Yeong Su Ha; Subramani Rajkumar; Bora Nam; Jeong Eun Lim; Phuong Tu Huynh; Kiwoong Lee; Ji-Yoon Son; Jung Young Kim; Kyo Chul Lee; Jeongsoo Yoo
Journal:  Pharmaceutics       Date:  2022-08-12       Impact factor: 6.525

9.  Cancer cell response to anthracyclines effects: mysteries of the hidden proteins associated with these drugs.

Authors:  Jirina Tyleckova; Rita Hrabakova; Katerina Mairychova; Petr Halada; Lenka Radova; Petr Dzubak; Marian Hajduch; Suresh J Gadher; Hana Kovarova
Journal:  Int J Mol Sci       Date:  2012-11-22       Impact factor: 5.923

10.  Concerted effects of heterogeneous nuclear ribonucleoprotein C1/C2 to control vitamin D-directed gene transcription and RNA splicing in human bone cells.

Authors:  Rui Zhou; Juw Won Park; Rene F Chun; Thomas S Lisse; Alejandro J Garcia; Kathryn Zavala; Jessica L Sea; Zhi-Xiang Lu; Jianzhong Xu; John S Adams; Yi Xing; Martin Hewison
Journal:  Nucleic Acids Res       Date:  2016-09-26       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.